News | October 18, 2017

AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif. – Oct. 18, 2017 – AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Harpoon Therapeutics, a biotechnology company developing...

News | August 23, 2017

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma – First ACTR Combination Therapy Under Unum’s Collaboration with Seattle Genetics –...

News | August 22, 2017

CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies Collaboration expands CRISPR Therapeutics’ efforts in immuno-oncology ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE...

News | August 15, 2017

Oxford Immunotec Global PLC Announces Pricing of Underwritten Public Offering of Ordinary Shares OXFORD, United Kingdom and MARLBOROUGH, Mass., August 15, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company...

News | August 15, 2017

Binary Fountain and Kyruus Announce Partnership to Enhance Patient Acquisition and Engagement for Health Systems by Kyruus, on Aug 15, 2017 8:55:42 AM The seamless integration of Binary Star Ratings and Kyruus ProviderMatch for Consumers will enable health systems to...